ARCHIVES

ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?

This article is from The Cancer Letter archive.

Vol. 28 No. 41 | November 8, 2002

Download PDF Visit The Full Archive

Related Articles

ONS Award Winners, Grantees, Announced At Annual Congress

July 27, 1990

FDA Approves Inlyta Pill For Renal Cell Carcinoma

January 27, 2012

Scientific Community Rallies To Support DeVita; Immediate Suspension Of Straus’ Grant Considered

June 12, 1981

PRI Purchased By DynCorp; NCI Is Assured No Changes Will Be Made At Frederick

April 13, 1990

Breslow Says NCI, Centers, States Should Collaborate On Cancer Control

June 1, 1984

Funding opportunities listed.

May 7, 2004